Serina Therapeutics Inc. (SER) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
4.97
-0.01 (-0.20%)
At close: Sep 26, 2025, 3:54 PM
4.93
-0.80%
After-hours: Sep 26, 2025, 06:22 PM EDT

Serina Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.31 21.96 -7.93 -33.16
PEG Ratio
0.01 -0.18 0.11 1.61
PS Ratio
658.37 36.69 42.53 13.80
PB Ratio
57.52 21.15 -1.24 -3.54
P/FCF Ratio
-2.15 -38.82 -10.2 -17.78
P/OCF Ratio
-2.15 -46.72 -10.25 -18.63
OCF/S Ratio
-306.02 -0.79 -4.15 -0.74
Debt / Equity Ratio
0.42 0.80 -0.11 -0.03
Quick Ratio
2.40 1.29 1.25 3.58
Current Ratio
2.40 1.29 1.25 3.58
Asset Turnover
0.01 0.26 0.58 1.65
Interest Coverage
-32.41 -5.61 -142.99 -527.31
Return on Equity
-17.38 0.96 0.16 0.11
Return on Assets
-1.66 0.44 -3.13 -0.69
Return on Invested Capital
-3.91 -0.19 -4.14 -0.18
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-2.46 0.97 0.71 -0.04
Net Profit Margin
-198.95 1.67 -5.36 -0.42
Pretax Profit Margin
-198.95 1.67 -5.36 -0.42
Operating Profit Margin
-304.43 -0.99 -4.54 -0.54
FCF Margin
-306.41 -0.95 -4.17 -0.78
EBITDA Margin
-187.27 1.88 -14.11 -2.42